DuPont completes the 2019 acquisitions of Desalitech, inge GmbH, Memcor and OxyMem Limited, adding to its portfolio of water purification and separation technologies including ultrafiltration, reverse osmosis and ion exchange resins. The four recent acquisitions support DuPont’s goal to increase access to the products and technologies needed to meet global customers’ current and future challenges, including the increased need to recycle water while reducing the energy requirements to generate clean water, according to the company.
“Water scarcity is a global challenge that needs to be solved with a sense of urgency. As a global leader in innovative water technologies, we are continually expanding our technology portfolio of high-quality solutions to help our customers purify, conserve and reuse this precious resource,” says HP Nanda, global vice president and general manager, DuPont Water Solutions. “We look forward to working with equipment manufacturers, end users and other value chain partners in a variety of business models, solving their water challenges and delivering superior value.”
The recent acquisitions further broaden DuPont’s portfolio and enhance the company’s ability to accelerate innovation and offer customers better levels of service, while reducing the life cycle costs of clean water. The four companies being added to the DuPont Water Solutions portfolio include:
· inge GmbH, an ultrafiltration membrane business acquired from BASF. The transaction included the business’ international workforce of about 150 employees, its headquarters and production site in Greifenberg, Germany and associated intellectual property owned by BASF SE.
· Memcor, the ultrafiltration and membrane bioreactor (MBR) technologies division from Evoqua Water Technologies Corp. The transaction included a manufacturing facility in Australia and about 200 employees.
· Desalitech Ltd: a closed-circuit reverse osmosis (CCRO) company. Desalitech’s CCRO technology addresses increasing needs for high water recovery in core market segments such as food and beverage, municipal, microelectronics and power. The transaction included the company (brands and product portfolio), intellectual property, and a 40-person workforce.
· OxyMem Limited, a company that develops and produces Membrane Aerated Biofilm Reactor (MABR) technology for the treatment and purification of municipal and industrial wastewater. The transaction included all intellectual property, more than 60 employees and one production site located in Athlone, Ireland.
For more information, visit: www.dupont.com
